Page last updated: 2024-10-16

butyric acid and Diabetes Mellitus, Adult-Onset

butyric acid has been researched along with Diabetes Mellitus, Adult-Onset in 16 studies

Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Urinary concentrations of Citrate and Butyric Acid showed statistical significance between Type 2 DM with Post Stroke Depression (PSD) and Type 2DM without Post Stroke Depression (PSD), with chi square test values of ϰ2=11."8.12Urinary Citrate and Butyric Acid as Early Biomarkers for Diagnosing Post Stroke Depression in T2dM. ( Mp, R, 2022)
"Urinary concentrations of Citrate and Butyric Acid showed statistical significance between Type 2 DM with Post Stroke Depression (PSD) and Type 2DM without Post Stroke Depression (PSD), with chi square test values of ϰ2=11."4.12Urinary Citrate and Butyric Acid as Early Biomarkers for Diagnosing Post Stroke Depression in T2dM. ( Mp, R, 2022)
"Acetic acid, propionic acid, butyric acid, and total SCFA were significantly reduced in T2D patients compared to overweight/obese in the unadjusted model."4.12Circulating short-chain fatty acids in type 2 diabetic patients and overweight/obese individuals. ( Annuzzi, G; Bozzetto, L; Corrado, A; Costabile, G; Della Pepa, G; Giacco, R; Luongo, D; Rivellese, AA; Salamone, D; Testa, R; Vitale, M, 2022)
"Understanding role of microbiota in type 2 diabetes and the mechanisms connecting T2DM and alterations in gut microbiota could be the key to improved treatment of T2DM."2.72Could the use of butyric acid have a positive effect on microbiota and treatment of type 2 diabetes? ( Bohatyrewicz, A; Dzieżyc, A; Stachowska, E; Wiśniewska, M, 2021)
"The complication of type 2 diabetes (T2D) exacerbates brain infarction in acute ischemic stroke (AIS)."1.62Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury. ( Gao, X; He, Y; Li, J; Song, W; Tan, C; Wang, H; Wu, Q; Yin, J; Zhou, H; Zhu, J, 2021)
"Consequently, NaB mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of ERS."1.48Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress. ( Chen, J; Cheng, S; Hu, Y; Liu, J; Wang, H; Xu, Y; Yuan, Y, 2018)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's1 (6.25)29.6817
2010's6 (37.50)24.3611
2020's8 (50.00)2.80

Authors

AuthorsStudies
Wang, H5
Song, W2
Wu, Q1
Gao, X2
Li, J2
Tan, C1
Zhou, H2
Zhu, J1
He, Y1
Yin, J1
Mp, R1
Salamone, D1
Costabile, G1
Corrado, A1
Della Pepa, G1
Vitale, M1
Giacco, R1
Luongo, D1
Testa, R1
Rivellese, AA1
Annuzzi, G1
Bozzetto, L1
Wang, K2
Wang, Y1
Chen, S2
Gu, J1
Ni, Y1
Dariushnejad, H1
Pirzeh, L1
Roshanravan, N2
Ghorbanzadeh, V1
Alamdari, NM1
Jafarabadi, MA1
Mohammadi, A1
Shabestari, BR1
Nasirzadeh, N1
Asghari, S1
Mansoori, B1
Akbarzadeh, M1
Ghavami, A1
Ghaffari, S1
Ostadrahimi, A1
Yang, T1
Yang, H1
Heng, C1
Hu, Y3
Jiang, Z1
Yu, Q1
Wang, Z1
Qian, S1
Wang, J1
Wang, T1
Du, L1
Lu, Q1
Yin, X1
Stachowska, E1
Wiśniewska, M1
Dzieżyc, A1
Bohatyrewicz, A1
Matheus, VA1
Monteiro, L1
Oliveira, RB1
Maschio, DA1
Collares-Buzato, CB1
Pelgrim, CE1
Franx, BAA1
Snabel, J1
Kleemann, R1
Arnoldussen, IAC1
Kiliaan, AJ1
Winiczenko, R1
Górnicki, K1
Kaleta, A1
Janaszek-Mańkowska, M1
Khan, ZA1
Singh, C1
Khan, T1
Ganguly, M1
Bradsher, C1
Goodwin, P1
Petty, JT1
Sandau, C1
Bove, DG1
Marsaa, K1
Bekkelund, CS1
Lindholm, MG1
Salazar, J1
Bermúdez, V1
Olivar, LC1
Torres, W1
Palmar, J1
Añez, R1
Ordoñez, MG1
Rivas, JR1
Martínez, MS1
Hernández, JD1
Graterol, M1
Rojas, J1
Mubarak, Z1
Humaira, A1
Gani, BA1
Muchlisin, ZA1
Gremillet, C1
Jakobsson, JG1
Gomila, A1
Shaw, E1
Carratalà, J1
Leibovici, L1
Tebé, C1
Wiegand, I1
Vallejo-Torres, L1
Vigo, JM1
Morris, S1
Stoddart, M1
Grier, S1
Vank, C1
Cuperus, N1
Van den Heuvel, L1
Eliakim-Raz, N1
Vuong, C1
MacGowan, A1
Addy, I1
Pujol, M1
Cobb, A1
Rieger, E1
Bell, J1
Mallik, S1
Zhao, Z1
Szécsényi, Á1
Li, G1
Gascon, J1
Pidko, EA1
Zhang, GR1
Wolker, T1
Sandbeck, DJS1
Munoz, M1
Mayrhofer, KJJ1
Cherevko, S1
Etzold, BJM1
Lukashuk, L1
Yigit, N1
Rameshan, R1
Kolar, E1
Teschner, D1
Hävecker, M1
Knop-Gericke, A1
Schlögl, R1
Föttinger, K1
Rupprechter, G1
Franconieri, F1
Deshayes, S1
de Boysson, H1
Trad, S1
Martin Silva, N1
Terrier, B1
Bienvenu, B1
Galateau-Sallé, F1
Emile, JF1
Johnson, AC1
Aouba, A1
Vogt, TJ1
Gevensleben, H1
Dietrich, J1
Kristiansen, G1
Bootz, F1
Landsberg, J1
Goltz, D1
Dietrich, D1
Idorn, M1
Skadborg, SK1
Kellermann, L1
Halldórsdóttir, HR1
Holmen Olofsson, G1
Met, Ö1
Thor Straten, P1
Johnson, LE1
Brockstedt, D1
Leong, M1
Lauer, P1
Theisen, E1
Sauer, JD1
McNeel, DG1
Morandi, F1
Marimpietri, D1
Horenstein, AL1
Bolzoni, M1
Toscani, D1
Costa, F1
Castella, B1
Faini, AC1
Massaia, M1
Pistoia, V1
Giuliani, N1
Malavasi, F1
Qiu, J1
Peng, S1
Yang, A1
Ma, Y1
Han, L1
Cheng, MA1
Farmer, E1
Hung, CF1
Wu, TC1
Modak, S1
Le Luduec, JB1
Cheung, IY1
Goldman, DA1
Ostrovnaya, I1
Doubrovina, E1
Basu, E1
Kushner, BH1
Kramer, K1
Roberts, SS1
O'Reilly, RJ1
Cheung, NV1
Hsu, KC1
Salgarello, T1
Giudiceandrea, A1
Calandriello, L1
Marangoni, D1
Colotto, A1
Caporossi, A1
Falsini, B1
Lefrançois, P1
Xie, P1
Wang, L2
Tetzlaff, MT1
Moreau, L1
Watters, AK1
Netchiporouk, E1
Provost, N1
Gilbert, M1
Ni, X1
Sasseville, D1
Wheeler, DA1
Duvic, M1
Litvinov, IV1
O'Connor, BJ1
Fryda, NJ1
Ranglack, DH1
Yang, Y2
Yang, J1
Zhang, X2
Grün, AL1
Emmerling, C1
Aumeeruddy-Elalfi, Z1
Ismaël, IS1
Hosenally, M1
Zengin, G1
Mahomoodally, MF1
Dotsenko, A1
Gusakov, A1
Rozhkova, A1
Sinitsyna, O1
Shashkov, I1
Sinitsyn, A1
Hong, CE1
Kim, JU1
Lee, JW1
Lee, SW1
Jo, IH1
Pandiyarajan, S1
Premasudha, P1
Kadirvelu, K1
Wang, B1
Luo, L1
Wang, D1
Ding, R1
Hong, J1
Caviezel, D1
Maissen, S1
Niess, JH1
Kiss, C1
Hruz, P1
Pockes, S1
Wifling, D1
Keller, M1
Buschauer, A1
Elz, S1
Santos, AF1
Ferreira, IP1
Pinheiro, CB1
Santos, VG1
Lopes, MTP1
Teixeira, LR1
Rocha, WR1
Rodrigues, GLS1
Beraldo, H1
Lohar, S1
Dhara, K1
Roy, P1
Sinha Babu, SP1
Chattopadhyay, P1
Sukwong, P1
Sunwoo, IY1
Lee, MJ1
Ra, CH1
Jeong, GT1
Kim, SK2
Huvinen, E1
Eriksson, JG1
Stach-Lempinen, B1
Tiitinen, A1
Koivusalo, SB1
Malhotra, M1
Suresh, S1
Garg, A1
Wei, L1
Jiang, Y2
Zhou, W1
Liu, S1
Liu, Y1
Rausch-Fan, X1
Liu, Z1
Marques, WL1
van der Woude, LN1
Luttik, MAH1
van den Broek, M1
Nijenhuis, JM1
Pronk, JT1
van Maris, AJA1
Mans, R1
Gombert, AK1
Xu, A1
Sun, J1
Chen, W2
Zheng, R1
Han, Z1
Ji, L1
Shen, WQ1
Bao, LP1
Hu, SF1
Gao, XJ1
Xie, YP1
Gao, XF1
Huang, WH1
Lu, X1
Gostin, PF1
Addison, O1
Morrell, AP1
Zhang, Y2
Cook, AJMC1
Liens, A1
Stoica, M1
Ignatyev, K1
Street, SR1
Wu, J1
Chiu, YL1
Davenport, AJ1
Qiu, Z1
Shu, J1
Tang, D1
Zhang, J3
Huang, K1
Wai, H1
Du, K1
Anesini, J1
Kim, WS1
Eastman, A1
Micalizio, GC1
Liang, JH1
Huo, XK1
Cheng, ZB1
Sun, CP1
Zhao, JC1
Kang, XH1
Zhang, TY1
Chen, ZJ1
Yang, TM1
Wu, YY1
Deng, XP1
Zhang, YX1
Salem, HF1
Kharshoum, RM1
Abou-Taleb, HA1
AbouTaleb, HA1
AbouElhassan, KM1
Ohata, C1
Ohyama, B1
Kuwahara, F1
Katayama, E1
Nakama, T1
Kobayashi, S1
Kashiwagi, T1
Kimura, J1
Lin, JD1
Liou, MJ1
Hsu, HL1
Leong, KK1
Chen, YT1
Wang, YR1
Hung, WS1
Lee, HY1
Tsai, HJ1
Tseng, CP1
Alten, B1
Yesiltepe, M1
Bayraktar, E1
Tas, ST1
Gocmen, AY1
Kursungoz, C1
Martinez, A1
Sara, Y1
Huang, S2
Adams, E1
Van Schepdael, A1
Wang, Q1
Chung, CY1
Yang, W1
Yang, G1
Chough, S1
Chen, Y1
Yin, B1
Bhattacharya, R1
Saeui, CT1
Yarema, KJ1
Betenbaugh, MJ1
Zhang, H1
Patik, JC1
Tucker, WJ1
Curtis, BM1
Nelson, MD1
Nasirian, A1
Park, S1
Brothers, RM1
Dohlmann, TL1
Hindsø, M1
Dela, F1
Helge, JW1
Larsen, S1
Gayani, B1
Dilhari, A1
Wijesinghe, GK1
Kumarage, S1
Abayaweera, G1
Samarakoon, SR1
Perera, IC1
Kottegoda, N1
Weerasekera, MM1
Nardi, MV1
Timpel, M1
Ligorio, G1
Zorn Morales, N1
Chiappini, A1
Toccoli, T1
Verucchi, R1
Ceccato, R1
Pasquali, L1
List-Kratochvil, EJW1
Quaranta, A1
Dirè, S1
Heo, K1
Jo, SH1
Shim, J1
Kang, DH1
Kim, JH1
Park, JH1
Akhtar, N1
Saha, A1
Kumar, V1
Pradhan, N1
Panda, S1
Morla, S1
Kumar, S1
Manna, D1
Xu, E1
Yu, S1
Li, D1
Quan, J1
Xu, L1
Saslow, SA1
Um, W1
Pearce, CI1
Bowden, ME1
Engelhard, MH1
Lukens, WL1
Kim, DS1
Schweiger, MJ1
Kruger, AA1
Adair, LS1
Kuzawa, C1
McDade, T1
Carba, DB1
Borja, JB1
Liang, X2
Zhang, B1
Peele, ME1
Luo, HR1
Chen, ZY1
Fei, JJ1
Du, ZJ1
Yi, KJ1
Im, WT1
Kim, DW1
Ji, X1
Zhang, C1
Xu, Z1
Ding, Y1
Song, Q1
Li, B2
Zhao, H1
Lee, DW1
Lee, H1
Kwon, BO1
Khim, JS1
Yim, UH1
Park, H1
Park, B1
Choi, IG1
Kim, BS1
Kim, JJ1
Wang, JJ1
Chen, Q1
Li, YZ1
Sakai, M1
Yamaguchi, M1
Nagao, Y1
Kawachi, N1
Kikuchi, M1
Torikai, K1
Kamiya, T1
Takeda, S1
Watanabe, S1
Takahashi, T1
Arakawa, K1
Nakano, T1
Rufo, S1
Continentino, MA1
Nikolaou, V1
Plass, F1
Planchat, A1
Charisiadis, A1
Charalambidis, G1
Angaridis, PA1
Kahnt, A1
Odobel, F1
Coutsolelos, AG1
Fuentes, I1
García-Mendiola, T1
Sato, S1
Pita, M1
Nakamura, H1
Lorenzo, E1
Teixidor, F1
Marques, F1
Viñas, C1
Liu, F1
Qi, P1
Zhang, L2
Liu, J1
Yuan, Y1
Chen, J1
Cheng, S1
Xu, Y2
Zhang, WQ1
Zhao, TT1
Gui, DK1
Gao, CL1
Gu, JL1
Gan, WJ1
Huang, W1
Chen, WN1
Liu, ZL1
Xu, YH1
Du, J1
Yano, N1
Zhao, YT1
Dubielecka, PM1
Zhuang, S1
Chin, YE1
Qin, G1
Zhao, TC1
Liu, W1
Liu, K1
Wood, HB1
McCann, ME1
Doebber, TW1
Chang, CH1
Akiyama, TE1
Einstein, M1
Berger, JP1
Meinke, PT1
Marchetti, P1
Gregorio, F1
Benzi, L1
Giannarelli, R1
Cecchetti, P1
Villani, G1
Di Cianni, G1
Di Carlo, A1
Brunetti, P1
Navalesi, R1

Reviews

1 review available for butyric acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Could the use of butyric acid have a positive effect on microbiota and treatment of type 2 diabetes?
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:13

    Topics: Butyric Acid; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; M

2021

Trials

2 trials available for butyric acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Cytokine, 2020, Volume: 131

    Topics: Administration, Oral; Adult; Antioxidants; Butyric Acid; Diabetes Mellitus, Type 2; Dietary Suppleme

2020
    Neural computing & applications, 2018, Volume: 30, Issue:6

    Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosp

2018

Other Studies

13 other studies available for butyric acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury.
    Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2

    Topics: Animals; Brain Infarction; Brain Injuries; Butyric Acid; Cytokines; Diabetes Mellitus, Type 2; Fecal

2021
Urinary Citrate and Butyric Acid as Early Biomarkers for Diagnosing Post Stroke Depression in T2dM.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:4

    Topics: Biomarkers; Butyric Acid; Citric Acid; Depression; Diabetes Mellitus, Type 2; Humans; Quality of Lif

2022
Circulating short-chain fatty acids in type 2 diabetic patients and overweight/obese individuals.
    Acta diabetologica, 2022, Volume: 59, Issue:12

    Topics: Acetic Acid; Butyric Acid; Diabetes Mellitus, Type 2; Fatty Acids, Volatile; Humans; Obesity; Overwe

2022
Insoluble and Soluble Dietary Fibers from Kiwifruit (
    Nutrients, 2022, Aug-17, Volume: 14, Issue:16

    Topics: Actinidia; Animals; Butyric Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Fiber; Gastroin

2022
Sodium butyrate and voluntary exercise through activating VEGF-A downstream signaling pathway improve heart angiogenesis in type 2 diabetes.
    Microvascular research, 2023, Volume: 147

    Topics: Animals; Butyric Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Physical Conditio

2023
Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice.
    Food & function, 2020, Dec-01, Volume: 11, Issue:12

    Topics: Animals; Blood Glucose; Butyric Acid; Caco-2 Cells; Cholesterol; Clostridium butyricum; Colon; Cytok

2020
Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.
    Experimental biology and medicine (Maywood, N.J.), 2017, Volume: 242, Issue:12

    Topics: Animals; Butyric Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Fatty Liver;

2017
Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.
    Nutrients, 2017, Jul-07, Volume: 9, Issue:7

    Topics: Adipocytes; Adipokines; Adipose Tissue; Animals; Butyric Acid; Cell Size; Diabetes Mellitus, Type 2;

2017
Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress.
    Environmental toxicology and pharmacology, 2018, Volume: 64

    Topics: Animals; Butyric Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; eIF-2 Kinase; End

2018
Sodium Butyrate Improves Liver Glycogen Metabolism in Type 2 Diabetes Mellitus.
    Journal of agricultural and food chemistry, 2019, Jul-10, Volume: 67, Issue:27

    Topics: Animals; Blood Glucose; Butyric Acid; Diabetes Mellitus, Type 2; Fluorescent Antibody Technique; Gas

2019
Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:8

    Topics: Animals; Butyric Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; E

2017
Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.
    Journal of medicinal chemistry, 2009, Jul-23, Volume: 52, Issue:14

    Topics: Animals; Blood Glucose; Butyric Acid; Cell Line; Cholesterol; Cricetinae; Diabetes Mellitus, Type 2;

2009
Diurnal pattern of plasma metformin concentrations and its relation to metabolic effects in type 2 (non-insulin-dependent) diabetic patients.
    Diabete & metabolisme, 1990, Volume: 16, Issue:6

    Topics: Alanine; Blood Glucose; Butyrates; Butyric Acid; Circadian Rhythm; Diabetes Mellitus, Type 2; Glycer

1990